Lopende projecten
In dit overzicht vindt u informatie over lopende onderzoeken waarbij data van SHM worden gebruikt. De lijst is gefilterd en toont alleen projecten die beschikbaar zijn voor een breed publiek. Wilt u meer weten over de stand van zaken in een project of een overzicht van de laatste publicaties, bekijk dan de publicaties in ons jaarverslag.
Bekijk het laatste jaarverslag
| SHM nr. | Titel project | Auteur(s) |
| I21115 | Outcomes of cervical cander screening in women living with HIV in Amsterdam | M.F. Schim van der Loeff, S.E. Geerlings, J.A. Kramer, H.R. Verhoeve, S.J. Bogers, D.A.M. Heideman, M.C.G. Bleeker, K. Brinkman, K. Sigaloff, M. van der Valk |
| I21114 | Know the local HIV epidemiology: map the numbers | H. Götz, D. Twisk, J. den Hollander, C. Rokx, A. van Sighem |
| I21113 | Prospects of HIV elimination among Dutch MSM by targeted screening, partner notification, and immediate ART initiation for acute HIV infection | G. Rozhnova, M. Werkman, M. Kretzschmar, A. van Sighem, P. Reiss, J. Heijne, M. Dijkstra, W. Zuilof, G. de Bree, M. Schim van der Loeff |
| I20111 | Limburg 4 zero: An integrated approach to reduce the number of HIV and sexually transmitted infections in Limburg | N. Dukers-Muijers, Y. Evers, H. Goense, R. Ackens, M. Pronk, R. van Crevel, O. Richel |
| I20110 | Clinical outcomes and inflammation in viremic and non-viremic HIV elite controllers in the Dutch Athena Cohort | A. Verbon, A. van der Ven, M. Netea, A. Groenendijk, W. Blok, M. Berrevoets |
| I20109 | Update on trends in incidence and risk factors of anal cancer in HIV-infected patients | J. Prins, H. de Vries, P. Reiss, F. Wit, C. Smit, R.P. van der Zee |
| I20108 | Determining factors associated with disproportional weight gain in people with HIV with suppressed viremia switching antiretroviral therapy to an INSTI and/or TAF-containing regimen |
P. Reiss, M. Verburgh, F. Wit, S. Verboeket, A. Boyd, M. van der Valk |
| I20107 | HIV in Gelderland: characteristics of the infected population and testing behaviour among general practitioners | N. Nijsten, O. Richel, C. van Jaarsveld, G. ter Beest, K. Grintjes, A. van Sighem, R. van der Bij, S. Ostendorf, P. Dielissen, M. van de Luijtgaarden, R. Hermsen, C. van der Starre |
| I19105 | Remaining barriers to advancing hepatitis C micro-elimination in the HIV/HCV co-infected population in the Netherlands | M. van der Valk M, C. Isfordink, J. Arends, C. Smit, A. Boyd |
| I19104 | Long-term clinical and virological outcomes in aging perinatally and behaviourally HIV-infected young adults in the Netherlands (12-30 years) | A. Weijsenfeld, C. Blokhuis, C. Smit, M. van der Valk, F. Wit, D. Pajkrt |
| I19103 |
2000HIV Human Functional Genomics Partnership Programm (2000HIV study) |
A. van der Ven, M. Netea, L. Joosten, Q. de Mast, M. Jacobs-Cleophas, L. van Eekeren, M. Berrevoets, M. Blauw, A. Verbon, A. Groenendijk, W. Blok, W. Vos |
| I19100 | HIV treatment outcomes of transgender people versus the general HIV-positive population in the Netherlands |
C. Daans, E. Hoornenborg, M. den Heijer, |
| I17095 |
Evaluation of diagnosis, referral and treatment of acute HIV-1 infection at the Amsterdam STI clinic: trends over time |
De Bree G, Schim van der Loeff M, Dijkstra M, Prins M, Prins J, van Rooijen M, Hogewoning A, van Sighem AI |
| I17092 |
Impact of the Positive Sisters peer support program on health outcomes in HIV-positive migrant women in the Netherlands |
F. Cobelens, L. Darvey, M. Adhikari, S. Boender |
| I16060 |
Evaluation of dolutegravir use of the treatment of HIV in the Netherlands: focus on switchers and adverse events |
D. Burger, R. van Crevel, A. Brouwer, P. Bollen, J.E. Arends, C.S. Hakkers, I.M. Hoepelman, K. Brinkman, G.E.L. van den Berk, F.I. Wit |
| I16038 |
Immune reconstitution inflammatory syndrome associated with toxoplasmic encephalitis in HIV-infected patients: a multicentre cohort study |
P.H. Ward, W. van Bisen, C.H.S.B. van den Berg, B.J.A. Rijnders, K. Brinkman, J.W. Mulder, L.B.S. Gelinck, A.I.M. Hoepelman, F.W.N.M. Wit, D. van de Beek, J.M. Prins |
| I15066 |
Cost-effectiveness of HIV treatment and care in the Netherlands |
A. Verbon, B.E. Nichols, C. Boucher, S. Geerlings, P. Reiss, A. van Sighem, F.P. Kroon, M.J. Postma, K. Brinkman |
| I15004 | The impact of combinations of strategies for HIV prevention among men who have sex with men | M. Xiridu, A. van den Bosch, B. van Benthem, E. Op de Coul, A. van Sighem, I. Stolte |
| I14065 | Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients: Implications for screening strategies | G. Wandeler, A. Rauch, P. Reiss, C. Smit, M. van der Valk, J. Arends |
| I13120 | SPREAD Program 3.0 - Surveillance of transmission of HIV- drug resistace | A.M.J. Wensing, C.A.B. Boucher, K. Brinkman, J. van der Meer, I. van de Ende, C. Richter, E. Schippers, D. de Vries-Sluijs, J. Schinkel, C. Smit |
| I13051 | Barrières voor hiv-preventie, -testen en -zorg onder migranten (aMASE) | M. Prins, F. Zuure, J. Bil, F. Burns, J. del Amo |
| I13032 | Combined and Comparative Analysis of Virulence Trends Across Multiple Cohorts | L. Gras, F. de Wolf, J. Herbeck, V. Mueller |
| I12045 | A HIV-1 genome wide association study to identify viral determinants of HIV-1 plasma concentration (BEEHIVE) | F. de Wolf, B. Berkhout, M. Cornelissen, C. Fraser, P. Kellam, A. Gall, L. Gras, A. van Sighem |
| I08115 | Proposal for collaboration and data exchange between HMF and RIVM for nation HIV/AIDS surveillance and data transfer to ECDC in the context of EU obligations for reporting on HIV/AIDS | E. op den Coul, F. de Wolf, M. van der Sande, A. van Sighem, J. Vlug |
| I05513 | HIV Resistance Response Database Initiative (RDI) | A. Revell |
| I04034 | The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) | P. Reiss |